<DOC>
	<DOCNO>NCT02982655</DOCNO>
	<brief_summary>The purpose academic lead study explore ideal blood pressure target optimum individualized anti-hypertension strategy acute severe stroke .</brief_summary>
	<brief_title>Controlling Hypertension After Severe Cerebrovascular Event</brief_title>
	<detailed_description>Of high mortality morbidity , severe stroke associate devastating damage neurologic , respiratory , circulatory many system . The outcomes patient severe stroke depend largely medical strategy acute stage , especially blood pressure ( BP ) management . Unfortunately , far ideal BP range scientifically determine patient acute severe stroke . The CHASE study aim provide reliable data effect individualize anti-hypertension strategy patient acute severe stroke ( target recruitment 250 ) compare standard guideline-based management BP ( target recruitment 250 ) . Patients present acute ( &lt; 72h ) severe stroke ( GCS ≦ 12 NIHSS ≧ 11 ) elevate BP ( systolic blood pressure ≧150 mmHg diastolic blood pressure ≧ 100 mmHg ) randomly assign individualized anti-hypertension treatment guideline-based treatment 7 day .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Hydralazine</mesh_term>
	<mesh_term>Labetalol</mesh_term>
	<mesh_term>Phentolamine</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Nitroprusside</mesh_term>
	<criteria>Severe stroke occur 72 hour . GCS ≤12 NIHSS≥11 . Systolic blood pressure ≥ 150 mmHg diastolic blood pressure ≥ 100 mmHg admission . Able 'actively ' treat admit monitored facility . Informed consent . Received intravenous thrombolytic therapy . Concurrent severe heart failure . Concurrent acute myocardial infarction . Concurrent unstable angina . Concurrent severe systemic disease . Other serious lifethreatening disease stroke . Clear indication , clinician 's view , antihypertensive therapy acute phase stroke ( i.e . multiple cerebral artery stenosis , apparent cerebrovascular malformation aortic dissection , situation ) . Patient unavailable followup ( e.g . fixed address ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Severe Stroke</keyword>
	<keyword>Acute Stroke</keyword>
	<keyword>Antihypertension</keyword>
	<keyword>mortality</keyword>
	<keyword>disability</keyword>
	<keyword>clinical trial</keyword>
</DOC>